(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ASCENTAGE PHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ASCENTAGE PHARMA

ST13

US500000079331666

Class

35

Filing

79331666

Registration

7226796

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

52

Latest update

04/24/2026

Trademark type

Combined

Nice classes

35

Filing date

10/29/2021

Registration date

11/28/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/28/2023

Last transaction

04/24/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

98

Owner location

CN

Examiner

NEAL, KELLY L

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

ASCENTAGE PHARMA (SUZHOU) CO., LTD.
Jiangsu Ascentage Pharma Inc.

Representatives

Kathryn E. Smith Wood Herron & Evans LLP

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Retail and wholesale store services for pharmaceutical preparations; wholesale store services for veterinary medicine; publicity consultation; distribution of samples for publicity purposes; providing television home shopping services in the field of general consumer merchandise; marketing services; personnel recruitment; compilation of information into computer databases; updating and maintenance of data in computer databases; accounting services; rental of vending machines; sponsorship search; rental of sales stands; retail store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; retail and wholesale store services for medicine

Publications

History of USPTO decisions and trademark events.

52 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/23/2026

CHLD

CHANGE OF OWNER RECEIVED FROM IB

11/07/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/21/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

08/21/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/21/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/21/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/21/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

08/21/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/26/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/29/2024

FIMP

FINAL DISPOSITION PROCESSED

02/29/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/28/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/26/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/26/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/26/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/28/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

11/28/2023

RFNP

REFUSAL PROCESSED BY IB

09/12/2023

GPNX

NOTIFICATION PROCESSED BY IB

09/12/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/12/2023

PUBO

PUBLISHED FOR OPPOSITION

09/12/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/23/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/23/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/23/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/06/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/24/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/24/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/24/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/22/2023

GNRT

NON-FINAL ACTION E-MAILED

07/22/2023

CNRT

NON-FINAL ACTION WRITTEN

07/22/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

07/21/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

06/28/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

06/27/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/12/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/12/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

06/12/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

01/26/2023

GNFR

FINAL REFUSAL E-MAILED

01/26/2023

CNFR

FINAL REFUSAL WRITTEN

01/26/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/16/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/15/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/15/2022

RFNT

REFUSAL PROCESSED BY IB

07/06/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/15/2022

RFRR

REFUSAL PROCESSED BY MPU

06/15/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/18/2022

CNRT

NON-FINAL ACTION WRITTEN

05/17/2022

DOCK

ASSIGNED TO EXAMINER

04/29/2022

MAFR

APPLICATION FILING RECEIPT MAILED

02/01/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/28/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/27/2022

Continuous trademark protection

Get notified about every new filing that threatens ASCENTAGE PHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.